Cagrilintide 10 mg

Price: Original price was: CHF 169.00.Current price is: CHF 129.00.

Cagrilintide is a long-acting, lipidated analogue of the peptide hormone amylin. Supplied as a reference material for in-vitro amylin- and calcitonin-receptor research.

FOR LABORATORY RESEARCH ONLYIntended exclusively for in-vitro laboratory research by qualified professionals. Not approved or intended for human or veterinary use, consumption, or therapeutic applications. See our Research Use Disclaimer.

Description

Overview

Cagrilintide is a synthetic acylated analogue of amylin, designed for extended stability through fatty-acid conjugation. It is described as a non-selective agonist of amylin (AMY1โ€“3) and calcitonin receptors.

In the laboratory it is used in receptor-activation and cAMP-signalling assays and in peptide-stability studies. No claims are made regarding effects in humans or animals.

Typical in-vitro applications

  • Amylin and calcitonin receptor activation assays (cAMP readout)
  • Receptor-selectivity profiling
  • Lipidated-peptide stability and analytical method development

Compound data

  • Compound: Cagrilintide
  • Compound class: Acylated amylin analogue
  • Receptor class: Amylin (AMY1โ€“3) and calcitonin receptors
  • Net content: 10 mg per vial (stated for analytical and preparative calculations)
  • Purity specification: โ‰ฅ99% (HPLC); measured value on the lot certificate of analysis
  • Form: Lyophilised powder
  • Intended use: In-vitro laboratory research only

Storage & handling

  • Store the sealed vial at โˆ’20 ยฐC, dry and protected from light.
  • Allow the vial to reach room temperature before opening to avoid condensation.
  • Handle with standard laboratory protective equipment (gloves, lab coat, eye protection).
  • Shipped at ambient temperature in insulated, tamper-evident packaging.

Analytical documentation

HPLC purity and LC-MS identity are tested for every lot. Certificates of analysis and third-party test reports are published in our COA library on the About Us page.

For laboratory research use only. Not for human or veterinary use. See our Research Use Disclaimer.

Related Products

Tirzepatide is a synthetic acylated peptide that activates the GIP and GLP-1 receptors. Supplied as a reference material for in-vitro incretin-receptor research.
Semaglutide is a synthetic acylated analogue of glucagon-like peptide-1 (GLP-1). Supplied as a reference material for in-vitro GLP-1 receptor research.
Retatrutide is a synthetic acylated peptide that activates the GIP, GLP-1 and glucagon receptors. Supplied as a reference material for in-vitro incretin-receptor research.

Retatrutide is a synthetic acylated peptide that activates the GIP, GLP-1 and glucagon receptors. Supplied as a reference material for in-vitro incretin-receptor research.

MOTS-c is a 16-amino-acid peptide encoded in the mitochondrial 12S rRNA gene. Supplied as a reference material for in-vitro mitochondrial-signalling research.

Adipotide is a synthetic peptidomimetic combining a prohibitin-binding targeting motif with a pro-apoptotic (KLAKLAK)โ‚‚ domain. Supplied as a reference material for in-vitro vascular-targeting and apoptosis research.

5-Amino-1MQ is a small-molecule quinolinium compound used in biochemical and cell-culture studies as an inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT). Supplied as a reference material for in-vitro laboratory research.